Most cited article(s)

You have access
Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer
Edward T. Morgan, Kerry B. Goralski, Micheline Piquette-Miller, Kenneth W. Renton, Graham R. Robertson, Madhusudana R. Chaluvadi, Kellie A. Charles, Stephen J. Clarke, Marina Kacevska, Christopher Liddle, Terrilyn A. Richardson, Rohini Sharma and Christopher J. Sinal

Drug Metabolism and Disposition February 2008, 36 (2) 205-216; DOI: https://doi.org/10.1124/dmd.107.018747
You have access
Glucuronidation of Amines and Other Xenobiotics Catalyzed by Expressed Human UDP-Glucuronosyltransferase 1A3
Mitchell D. Green, Christopher D. King, Behnaz Mojarrabi, Peter I. Mackenzie and Thomas R. Tephly

Drug Metabolism and Disposition June 1998, 26 (6) 507-512;
You have access
A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro
Odette A. Fahmi, Tristan S. Maurer, Mary Kish, Edwin Cardenas, Sherri Boldt and David Nettleton

Drug Metabolism and Disposition August 2008, 36 (8) 1698-1708; DOI: https://doi.org/10.1124/dmd.107.018663
You have access
Evaluation of the Selectivity of In Vitro Probes and Suitability of Organic Solvents for the Measurement of Human Cytochrome P450 Monooxygenase Activities
Dean Hickman, Ji-Ping Wang, Yi Wang and Jashvant D. Unadkat

Drug Metabolism and Disposition March 1998, 26 (3) 207-215;
You have access
Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction
Odette A. Fahmi, Susan Hurst, David Plowchalk, Jack Cook, Feng Guo, Kuresh Youdim, Maurice Dickins, Alex Phipps, Amanda Darekar, Ruth Hyland and R. Scott Obach

Drug Metabolism and Disposition August 2009, 37 (8) 1658-1666; DOI: https://doi.org/10.1124/dmd.108.026252
You have access
EVALUATION OF 3′-AZIDO-3′-DEOXYTHYMIDINE, MORPHINE, AND CODEINE AS PROBE SUBSTRATES FOR UDP-GLUCURONOSYLTRANSFERASE 2B7 (UGT2B7) IN HUMAN LIVER MICROSOMES: SPECIFICITY AND INFLUENCE OF THE UGT2B7^*2 POLYMORPHISM
Michael H. Court, Soundarajan Krishnaswamy, Qin Hao, Su X. Duan, Christopher J. Patten, Lisa L. von Moltke and David J. Greenblatt

Drug Metabolism and Disposition September 2003, 31 (9) 1125-1133; DOI: https://doi.org/10.1124/dmd.31.9.1125
You have access
SELECTIVITY OF SUBSTRATE (TRIFLUOPERAZINE) AND INHIBITOR (AMITRIPTYLINE, ANDROSTERONE, CANRENOIC ACID, HECOGENIN, PHENYLBUTAZONE, QUINIDINE, QUININE, AND SULFINPYRAZONE) “PROBES” FOR HUMAN UDP-GLUCURONOSYLTRANSFERASES
Verawan Uchaipichat, Peter I. Mackenzie, David J. Elliot and John O. Miners

Drug Metabolism and Disposition March 2006, 34 (3) 449-456; DOI: https://doi.org/10.1124/dmd.105.007369
You have access
Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel

Drug Metabolism and Disposition March 2001, 29 (3) 242-251;
You have access
Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines
Akiko Nakamura, Miki Nakajima, Hiroyuki Yamanaka, Ryoichi Fujiwara and Tsuyoshi Yokoi

Drug Metabolism and Disposition August 2008, 36 (8) 1461-1464; DOI: https://doi.org/10.1124/dmd.108.021428
You have access
A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES
Robert J. Riley, D. F. McGinnity and R. P. Austin

Drug Metabolism and Disposition September 2005, 33 (9) 1304-1311; DOI: https://doi.org/10.1124/dmd.105.004259

Main menu

User menu

Search

Most cited article(s)

Pages

Navigate

More Information

ASPET's Other Journals